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Abstract
Background: Occurrence of symptomatic, paroxysmal or persistent atrial fibrillation (AF) 
prior to admission to hospital for the purposes of cardiac surgery constitutes an indication for 
consideration of simultaneous surgical radiofrequency (RF) ablation of such tachyarrhythmia. 
The aim of this study was to evaluate the efficacy of surgical RF ablation in the treatment of 
AF with the application of ECG teletransmission in monitoring patients during a 6-month 
follow-up period. Furthermore, clinical and echocardiographic risk factors for arrhythmia re-
currences were subject to analysis. As per authors’ knowledge and literature review, so far no 
papers devoted to the assessment of efficacy of surgical RF ablation with the use of systematic 
ECG teletransmission have been published.
Methods: The study enrolled 61 patients (20 females) suffering from AF who underwent 
cardiac surgeries and were additionally subject to surgical RF ablation. The mean age of the 
subjects was 64 ± 9 years. Efficacy of the procedure was monitored with the application of a 
system enabling transtelephonic transmission of ECG signal. The study cohort was monitored 
in the period of 6 months. 2198 ECG recordings were obtained for analysis. 
Results: In the post-hospital follow-up period, no recurrences of AF were observed in the case 
of 40 (65%) subjects. Post-hospital failure of the surgical RF ablation procedure was associated 
with an early episode of AF during hospitalization (p = 0.0012), application of monopolar 
electrode (p = 0.0325) as well as with the surgical procedure performed to treat mitral stenosis 
(p = 0.0268). 
Conclusions: Moreover, it was observed that the group of patients without arrhythmia recur-
rence in the follow-up period was more frequently administered with antiarrhythmic medica-
tions (p = 0.0409) and statin (p = 0.0453) prior to the ablation procedure, with statin being 
more often applied after the procedure (tendency, p = 0.0747). As opposed to ablation in one 
atrium, biatrial ablation did not result in fewer late arrhythmia recurrences. (Cardiol J 2013; 
20, 5: 499–505)
Key words: atrial fibrillation, surgical radiofrequency ablation, cardiac surgeries,  
tele-electrocardiography, biatrial ablation
Figure 1. Additional lines made in the course of endo-
cardial ablation.
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Introduction
Lack of normal atrial systolic function in pa-
tients suffering from atrial fibrillation (AF) decre-
ases cardiac output by as much as 30% and may 
be symptomatic. AF increases the risk of stroke 
5 to 8 times with a 2-fold higher risk of death 
[1, 2]. Treatment of AF currently involves strategies 
of sinus rhythm maintenance or control of ventri-
cular rhythm frequency. Ablation is recommended 
in patients with symptomatic AF resistant to 
antiarrhythmic medications. Restoration of sinus 
rhythm is also recommended during valvular defect 
surgery or cardiac revascularization [3–5]. Applica-
tion of at least 2 methods of monitoring increases 
the chance of detecting arrhythmia recurrence and 
facilitates decision-making concerning further an-
ticoagulation, especially in asymptomatic patients.
The aim of this study was to evaluate short- and 
mid-term results of surgical radiofrequency (RF) 
ablation using transtelephonic electrocardiogram 
monitoring (TTM) during a 6-month follow-up. 
Furthermore, clinical and echocardiographic risk 
factors for arrhythmia recurrence were analyzed.
Methods
We enrolled 61 patients (41 males, 20 females, 
mean age 64.5 ± 8.7). Prior to cardiac surgery, per-
sistent AF was found in 30 and paroxysmal arrhyth-
mia in 31 patients. RF ablation was performed with 
Cardioblate 68000 generator from Medtronic. Left 
and right pulmonary vein isolation and ligation of 
the left auricle with Prolene stitches was done 
in all patients. A bipolar electrode was used in 
40 (66%) patients. When a monopolar electrode was 
used, isolation of all openings of pulmonary veins 
was accompanied by creation of additional lines 
connecting pulmonary veins with one another and 
with the left auricle and of a ring in the vicinity 
of the P3 segment of the posterior mitral valve 
leaflet (Fig. 1). The ablation technique was cho-
sen depending on the cardiac surgery procedure. 
Patients without contraindications were placed 
on 24-h amiodarone infusion with subsequent oral 
treatment for 3 months [4, 5].
An analog telephone system was used by the 
patients to transmit the ECG signal once a week 
and in case of any rhythm disturbance or discom-
fort. Statistical analysis was performed with SAS 
9.2® (SAS Institute Inc., Cary, NC, USA). Categori-
cal data presented as frequencies and percentages 
were compared with the c2 test or Fisher’s exact 
test as appropriate. Continuous data were tested 
for normal distribution with the Kolmogorow-
-Smirnov test. Normally distributed variables are 
presented as means ± standard deviation, whereas 
the median and the inter-quartile range are given 
for non-normal variables. The statistical signifi-
cance of differences between normally distributed 
variables was checked with Student’s t-test and the 
Cochran-Cox test, depending on the homogeneity 
or heterogeneity of variation, respectively. In the 
case of non-normal distribution, the Mann-Whitney 
U test was used.  
Multivariate logistic regression analysis with 
stepwise selection was done to identify prognostic 
factors for post-hospital AF (dependent variable). 
A significance level of 0.2 and 0.25 was required 
for a variable to enter and remain in the model, 
respectively. Zero hypotheses were verified with 
the assumed level of statistical significance of 
a £ 0.05. Two-tailed testing methods were applied. 
Results
The follow-up period was 193 ± 96 days. 
Follow-up was slightly shorter in 6 patients due 
to their late enrollment. Follow-up was terminated 
after 6 months from ablation in all patients. Car-
diac surgery was performed for valvular defects in 
24 (39%), ischemic heart disease in 24 (39%) (Table 1). 
These groups did not differ significantly as to the 
frequency of arrhythmia recurrence (Table 2). 
Other 13 patients were submitted to complex sur-
gery. The number of telephone ECGs received was 
36 ± 15 per patient and 2,198 ECG in total. 97 (4%) 
ECGs could not be analyzed. 299 ECGs revealed 
supraventricular arrhythmia. AF was observed in 
29 patients with 3 episodes of atrial flutter and 
1 episode of atrial tachycardia.
Early (during hospitalization) postopera-
tive AF (POAF) events were observed in 29 
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story of persistent AF, critical stenosis of the right 
coronary artery, and surgical revascularization of 
coronary vessels with right atrial ablation (Table 3). 
Early POAF proved to be a prognostic factor 
for future rhythm disturbances. Post-hospital re-
currence of arrhythmia [group SR(–)] was observed 
in 21 (35%) patients, including 16 (76.2%) with 
early POAF. Preoperative persistent AF rather than 
paroxysmal AF (48.3% vs. 19.4%; p = 0.0176) was 
related to the failure of pulmonary vein isolation. 
Furthermore, the risk of unsuccessful ablation was 
greater in severe mitral stenosis revealed with 
echocardiography (p = 0.0268). There were more 
mitral valve surgeries (p = 0.0866) and more mono-
polar electrode procedures (p = 0.0325) in patients 
with AF recurrence. Moreover, intra-operative 
inotropes predisposed to AF (p = 0.0453). Re-
duction in the number of AF events was attributed 
to preoperative antiarrhythmic medication (p = 
= 0.0409) and to statin use (p = 0.0453, Tables 4, 5).
Multivariate logistic regression analysis for 
prediction of AF-free survival during a 6-month 
follow-up tested a number of models in which 
strongly correlated independent variables were 
verified separately. The following variables were 
included: type of AF (paroxysmal or persistent), 
POAF event, AF occurrence on the 1st day after 
surgery, regular sinus rhythm on discharge, use 
of monopolar electrode, significant mitral stenosis, 
mitral valve surgery, use of antiarrhythmic drugs 
prior to surgery, preoperative administration of 
statins, intraoperative use of inotropes, age, and 
aortic cross clamp time (Table 6).
Regular sinus rhythm on discharge, time of 
aortic clumping, significant mitral stenosis, and 
inotropes intraoperatively (in declining order of 
strength) were independent predictors of AF-free 
Table 1. Surgical procedures.
Parameter N = 61
AVR 4
AVR + MVR 3
AVR + MVP 2
AVR + MVP + TVP 1
AVR + CABG 3
AVR + CABG + ASD 1
AVR + CABG  
+ ascending aorta replacement
1
AVR + ascending aorta replacement 1
Ascending aorta replacement (Bentall) 1
MVR 2
MVR + TVP 4
MVR + AVP + TVP 1
MVR + TVP + CABG 1
MVR + CABG 1
MVP + TVP 2
MVP + TVP + ASD 2
MVP + TVP + CABG 1
MVP + COR TRIATRIORUM 1
MVP + CABG 2
TVP 1
TVP + CABG 1
Isolated surgery ablation 1
Isolated CABG 24 
AVR — aortic valve replacement; MVR — mitral valve replace-
ment; AVP — aortic valve plasty; MVP — mitral valve plasty; 
TVP — tricuspid valve plasty; CABG — coronary artery bypass 
grafting; ASD – atrial septal defect
Table 2. Comparison of patients following atrial fibrillation surgical ablation due to coronary heart 
disease or valvular heart disease.
Parameter CABG (n = 24) Valve disease (n = 24) P
History of paroxysmal AF 18 (75.0%) 7 (29.2%) 0.0015
POAF 13 (54.2%) 8 (33.3%) 0.1457
Post hospital AF (6 months) 7 (29.2%) 8 (33.3%) 0.7555
Diabetes mellitus type 2 11 (47.8%) 0 0.0001
Myocardial infarction 14 (60.9%) 0 < 0.0001
COPD 0 5 (21.7%) 0.0491
CK-MB max [U/L] 40 (17–127) 60 (27–158) < 0.0001
Aortic cross clamp time [min] 40 (0–42) 48 (36–90) < 0.0001
Left atrium diameter 43.4 ± 6.9 47.8 ± 6.8 0.0324
EF following surgery 50.2 ± 11.2 51.0 ± 9.2 0.0424
CABG — coronary artery bypass grafting; AF — atrial fibrillation; POAF — postoperative atrial fibrillation; COPD — chronic obstructive 
pulmonary disease; CK-MB — creatinine kinase-myocardial band; EF — ejection fraction
(49.1%) patients during the 1st (11 patients, 18%), 
2nd (8 patients, 13%), 3rd (5 patients, 8.5%) or ≥ 4th day 
(5 patients, 8.5%) after surgery. AF on the day of 
discharge was disclosed in 15 (25%) patients. The 
risk of early POAF was greater in patients with a hi-
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Table 4. Comparison of clinical and echocardiographic parameters in groups with stable sinus rhythm 
(SR+) and with post-hospital atrial fibrillation (SR–).
Parameter SR+ (n = 40) SR– (n = 21) P
Males 27 (67.5%) 15 (71.4%) 0.7529
Age [years] 64.5 ± 9.1 64.5 ± 8.1 0.9753
Body mass index [kg/m2] 28.9 ± 3.8 28.2 ± 3.2 0.4993
Follow-up period [days] 178 ± 104 202 ± 90 0.3475
Number of telephone reports 32.1 ± 15.5 42.0 ± 17.0 0.0278
Duration of AF prior to hospitalization [months] 15 (3–108) 7 (1 –84) 0.5606
Antiarrhythmics preop. 11 (29%) 1 (4.8%) 0.0409
Beta-blockers preop. 37 (97.4%) 20 (100%) 1.000
Statin preop. 28 (73.7%) 10 (47.6%) 0.0453
Left atrium diameter 45.4 ± 7.4 47.6 ± 5.4 0.2260
EF prior to surgery 51.7 ± 10.8 51.9 ± 10.9 0.9444
EF following surgery 50.0 ± 10.7 50.7 ± 9.0 0.7805
Diastolic left ventricle diameter [mm] 54.6 ± 7.9 52.1 ± 7.5 0.2741
TAPSE [mm] 22.1 ± 4.4 21.5 ± 4.2 0.7356
Intraventricular septum [mm] 12.2 ± 2.6 12.0 ± 2.6 0.7982
Significant mitral stenosis 3 (8.1%) 7 (33.3%) 0.0268
Max. CK-MB [U/L] 46.5 (20–182) 47 (17–108) 0.7972
Postoperative AF 12 (30.0%) 17 (81.0%) 0.0002
Nature of AF:
Permanent AF 15 (37.5%) 15 (71.4%)
0.0176Paroxysmal AF 25 (62.5%) 6 (28.6%)
AF — atrial fibrillation; EF — ejection fraction; preop. —  preoperatively; TAPSE — tricuspid annular plane systolic excursion;  
CK-MB — creatinine kinase-myocardial band
Table 3. Significant risk factors for postoperative atrial fibrillation (POAF+, n = 29).
Parameter POAF– (n = 32) POAF+ (n = 29) P
History of paroxysmal AF 21 (65.6%) 10 (34.5%) 0.0151
AF in the post-hospital period (6 months) 5 (15.6%) 16 (55.2%) 0.0012
Intraventricular septum [mm] 12.8 ± 2.9 11.4 ± 1.9 0.0453
Aortic stenosis 10 (33.3%) 1 (3.5%) 0.0032
Right coronary artery stenosis 6 (18.8%) 14 (48.3%) 0.0142
CABG 15 (46.9%) 21 (72.4%) 0.0428
Ablation of the right atrium 11 (34.4%) 17 (58.6%) 0.0577 (tendency)
POAF — postoperative atrial fibrillation; AF — atrial fibrillation; CABG — coronary artery bypass grafting
Table 5. Procedures and treatment in groups with stable sinus rythm (SR+) and with post-hospital 
atrial fibrillation (SR–).
Parameter SR+ (n = 40) SR– (n = 21) p
Time of aortic clamping [min] 44.8 ± 21.9 
38 (0–87)
55.2 ± 25.4 
60 (0–104)
0.1022 
0.1122
Number of anastomoses with coronary arteries 2.7 ± 1.0 2.5 ± 1.2 0.4748
Mitral valve surgery 12 (30%) 11 (52.5%) 0.0866 (tendency)
Monopolar electrode 10 (25%) 11 (52.4%) 0.0325
Ablation of the right atrium 18 (45%) 10 (47.6%) 0.8454
Inotropes intraoperatively 10 (26.3%) 11 (52.4%) 0.0453
Statin postoperatively 27 (71.1%) 10 (47.6%) 0.0747 (tendency)
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survival (area under ROC = 0.906, Fig. 2). AF type 
(paroxysmal or persistent) and surgery procedure 
(coronary artery bypass grafting or valve repair) 
were excluded as independent predictors of AF. How-
ever, it should be noted that the relatively small 
number of patients in the study group resulted in 
extended confidence intervals for odds ratios.
Discussion
The present findings and other reports demon-
strate that complex monitoring of patients following 
cardiac ablation should be routine. For example, 
Piorkowski et al. [6] found that the efficacy of abla-
tion decreased from 70% on the basis of symptoms 
to 50% or 45% with 7-day Holter ECG or TTM, 
respectively. The importance of monitoring is under-
scored by observations that paroxysmal AF, which 
is often asymptomatic, is associated with the same 
risk of thrombo-embolic complications as permanent 
arrhythmia [7, 8]. Consequently, assessment of the 
efficacy of ablation will steer the decision concerning 
continuation of oral anticoagulants.
We were unable to find studies analyzing the 
effects of surgical RF ablation with regular (weekly) 
telecardiometry. In the present study, the number 
of teletransmitted electrocardiograms averaged 
36 per patient, surprisingly more than the expected 
26. The usefulness of TTM was corroborated by 
the uncomplicated nature of the telephone adap-
ter and by the small percentage (4%) of distorted 
electrocardiograms. 
It is estimated that the success of RF ablation 
ranges from 40% to 90% [9–11]. The SAFS study 
[12] in 100 patients disclosed sinus rhythm in 75% 
of the patients after 6 months from ablation but with 
the 7-day Holter ECG the success rate decreased 
to 62%. Arrhythmia was not observed in 40 (65%) 
patients of our study group.
Occurrence of early POAF portends an unfavo-
rable prognosis since it is associated with a longer 
period of hospitalization and higher postoperative 
mortality. According to Echahidi et al. [7], POAF 
is observed in 50% of the patients undergoing 
complex operative procedures. POAF is the most 
frequent postoperative complication and usually 
occurs between the 2nd and 4th day following the 
procedure. In our study, POAF occurred on the 
1st and 2nd day in almost half of the patients. Due to 
multiple causes of early POAF, cardiology societies 
emphasize the importance of prevention and eli-
mination of factors implicated in POAF. Decisions 
must be made with care because recurrence of 
arrhythmia during the first 3 months after ablation 
(blanking period) does not necessarily prove the 
procedure to be unsuccessful.
Figure 2. Multivariate logistic regression models for 
independent predictors of atrial fibrillation-free survival.
Table 6. The independent predictors of survival without post-hospital atrial fibrillation.
Step Variable Odds  
ratio
95% confidence 
interval
P value  
(into model)
P value  
(Wald. Stat.)
1 Regular sinus rhythm on discharge 76.348 7.168–813.195 0.0005 0.0003
2 Significant mitral stenosis 0.049 0.003–0.751 0.0100 0.0302
3 Time of aortic clumping 0.957 0.919–0.996 0.0224 0.0299
4 Inotropes intraoperatively 0.136 0.022–0.834 0.1187 0.0311
5 Mitral valve surgery 5.604 0.449–69.920 0.0618 0.1808
6 Age 0.924 0.840–1.016 0.1681 0.1031
(C = 0.906); accuracy: 79.3%; sensitivity 83.8%; specificity: 71.4%
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Permanent arrhythmia turned out to be a con-
dition predisposing to late recurrence (p = 0.0176, 
Table 4), whereas early recurrence of POAF was 
an unfavorable prognostic factor (p = 0.0012). 
Similar findings were reported by Maroto et al. 
[13]. Preoperative use of antiarrhythmic drugs 
and statins in our patients resulted in less frequ-
ent recurrence of arrhythmia. The ARMYDA-3 
study showed that statins reduced the incidence 
of POAF [14, 15]. Statins are recommended for 
prophylaxis of arrhythmia in patients following 
coronary artery bypass grafting, irrespectively of 
heart valve surgery. However, other reports are 
not unequivocal concerning the role of statins in 
secondary prevention of tachyarrhythmia. For this 
reason, the European Society of Cardiology omits 
statins in its guidelines for this condition [16]. 
Oral amiodarone prophylaxis was predictive 
for POAF in our patients. In other studies, atrial 
and ventricular function improved in patients 
in whom SR was restored with extensive AAD 
therapy before ablation. Probably due to this fact, 
the recurrence of POAF was reduced [17–19]. 
Despite many reports on the efficacy of surgical 
isolation of pulmonary veins accompanying mitral 
valve surgery [19, 20], mitral stenosis was found 
by us to be an independent and distant factor for 
unsuccessful ablation (p = 0.0268). The use of 
the monopolar electrode significantly increased 
the rate of late recurrence of tachyarrhythmia 
(p = 0.0325). However, it should be emphasized 
that this subgroup had a slightly higher EURO-
SCORE and a longer history of arrhythmia. Similar 
findings were reported by Sielicki et al. [21].
In conclusion, TTM should be a routine recom-
mendation in patients who underwent surgical RF 
ablation, allowing for effective disclosure of rhythm 
disturbances. From the patient’s point of view, 
TTM gives the feeling of greater control and the 
possibility to obtain immediate physician’s advice.
Limitations of the study
The present paper has several limitations. The 
study was done on a heterogeneous group of pa-
tients regarding the type of pathology and technique 
for surgical ablation. However, our patient characte-
ristics match those in other studies on AF ablation. 
A TTM system was used for rhythm evaluation once 
per week and in case of symptoms or discomfort. 
In our opinion, this approach during 6 months from 
ablation constitutes an optimal monitoring method. 
Seven-day Holter ECG, although effective, is not 
a perfect tool either (long intervals). Combination of 
several methods could undoubtedly allow for better 
detection of arrhythmia episodes. It has been sugge-
sted that recurrences during the blanking period (usu-
ally 3 months after ablation) are not representative 
for the final clinical outcome (in our paper 20 out of 
21 patients have had AF burden during this stabi-
lization period as well as in the 6-month follow-up 
period). Moreover longer follow-up (e.g. 1 year) could 
have demonstrated different rates of recurrence. In 
our study extensive AAD therapy before ablation 
have resulted in a lower recurrence of post procedure 
AF. Although it has been confirmed in other studies 
published on AF ablation it also needs extended 
observation. Such echocardiography parameters like 
area or volume should also be calculated due to better 
left atrium assessment. 
Conclusions
Surgical RF ablation constitutes an effective 
method of treatment of AF (65% success rate) 
in patients subjected to revascularization and/or 
correction of heart defects. Electrocardiography 
teletransmission proved to be a useful tool for 
monitoring cardiac rhythm in patients with AF 
who underwent isolation of pulmonary veins 
during cardiac surgery. Ablation within both atria 
did not decrease the number of late recurrences 
of arrhythmia. Early recurrence of arrhythmia, 
severe mitral stenosis, as well as application of 
a monopolar electrode and inotropes were asso-
ciated with reduced success rate of ablation. Pre-
operative administration of antiarrhythmic drugs 
significantly reduced the number of AF events. 
Treatment with statins prior to surgery and during 
follow-up was associated with a tendency to redu-
ced number of AF events.
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